Unternehmensvergleich
Seitenweise Analyse von Lieferkettenposition, institutionellen Signalen und Nachrichten-Lückenwerten.
Marktkapitalisierung
Ketten-Rolle
Lückenwert
IB-Aktivität
Umsatzmix-Vergleich
Über
Eli Lilly is the world's most valuable pharmaceutical company, propelled by the blockbuster GLP-1 receptor agonist tirzepatide (Mounjaro/Zepbound) for diabetes and obesity. Its Alzheimer's antibody donanemab and strong oncology pipeline give it one of the most promising drug portfolios in the industry.
Gegründet
1876
Mitarbeiter
43,000+
Hauptsitz
Indianapolis, Indiana, USA
Umsatz
$52.8B
News-Gap-Signal
IB-Aktivität: HIGH
Institutionelle Signale
BlackRock
2024-08-13
BlackRock
2024-08-13
BlackRock
2024-08-13
Kaskadenmuster
Schlüsselbeziehungen
Über
Novo Nordisk is the global leader in diabetes care and has become a GLP-1 giant with Ozempic and Wegovy. The obesity-drug revolution has made it Europe's most valuable company. Its near-monopoly on injectable semaglutide positions it at the center of the $100B+ weight-loss drug market.
Gegründet
1923
Mitarbeiter
64,000+
Hauptsitz
Bagsvaerd, Denmark
Umsatz
$42.6B
News-Gap-Signal
IB-Aktivität: HIGH
Institutionelle Signale
BlackRock
2024-08-13
BlackRock
2024-08-13
BlackRock
2024-08-13